Aging and the response to inhibition and induction of theophylline metabolism.
The twofold to threefold higher incidence of adverse drug reactions in elderly as opposed to younger patients is due mainly to more severe disease and the requirement for more complex drug treatment regimens. The incidence of adverse drug reactions increases with the number of prescribed drugs. Because of multiple drug use by the elderly, the potential for drug interactions is greater in this patient group. Surprisingly, the effect of age on the clinical pharmacology of drug interactions has not been thoroughly investigated. Our studies have shown that cimetidine inhibits and phenytoin induces the metabolism of theophylline to a similar extent in healthy male nonsmokers and smokers. Preliminary analysis of the results of a study to investigate the inhibition of theophylline metabolism by cimetidine and ciprofloxacin administered in combination to healthy male and female nonsmokers also does not show an age difference in response. Additional careful studies are needed to evaluate further the pharmacology and clinical importance of pharmacokinetic and pharmacodynamic drug interactions in the elderly.